2 authorised products containing Lefamulin, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Xenleta 150 mg concentrate for solution for infusion EU/1/20/1457/001 |
Lefamulin | Nabriva Therapeutics Ireland Designated Activity Company | โ |
| Xenleta 600 mg film-coated tablets EU/1/20/1457/002 |
Lefamulin | Nabriva Therapeutics Ireland Designated Activity Company | โ |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (โAuthorised or Transfer Pending Productsโ), licensed CC BY 4.0, refreshed daily. Regulatory information only โ not medical advice.